Johnston SC, Ricks KM, Lakhal-Naouar I, Jay A, Subra C, Raymond JL, et al
By mimicking the action of the glucagon-like peptide-1 hormone, Semaglutide GLP-1 enhances feelings of fullness and decreases hunger, facilitating a reduction in caloric intake and supporting sustainable weight loss
#indianpharma #IP2026 #pharmaregulations #qualityassurance #healthcare #pharmanews To view or add a comment, sign in A major structural opportunity is emerging for Indian pharmaceutical companies
Initial approval of the first GLP-1RA, Exenatide, in 2006, followed by that of GLP-1RAs was swiftly followed up by randomized controlled trials (RCT) whose results revealed their role in treating T2D
Severe or ongoing dehydration can lead to serious or possibly fatal complications
AOD-9604 s selective mechanism functions regardless of baseline body composition, making it potentially effective even in relatively lean individuals